AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
6min chapter
Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
The HemOnc Pulse
Advancements in TKIs for Philadelphia Chromosome-Positive ALL
Exploring the effectiveness of different generations of TKIs in treating ALL, focusing on the emergence of the new inhibitor Brazii-1 and its potential to change standard practices. Comparison trials between Pronatinib and other TKIs highlight the superiority of Pronatinib and the benefits of choosing the most effective upfront treatment in acute leukemia cases.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode